Hyderabad-based Gland Pharma reported a 50 per cent increase in its consolidated net profit year-on-year (Y-o-Y), reaching ...

Q2 2025 Management View CEO Matthew Kaes Van’t Hof emphasized Diamondback’s continued focus on maximizing shareholder value, ...

Q2 2025 Management View CEO Christopher A. Tomasso reported "a strong quarter and encouraging underlying trends as First Watch's broad brand appeal and unit growth engine were on full display." He ...

Palantir's Q2 revenue surged 47.5%, AI adoption soared, and free cash flow grew 281%. Click for why PLTR's growth signals ...

Axogen reports strong Q2 2025 results with 18.3% revenue growth, raised guidance, and progress on BLA approval for Avance Nerve Graft.

DoorDash reports earnings after market close tomorrow. Its stock is up over 50% this year and over 400% since the beginning ...

Palantir Technologies' stock is up +6% today as the company reported a huge +53.6% increase in Q/Q free cash flow and a ...

Gland Pharma reported consolidated net profit rose nearly 50% for the June quarter to ₹215.5 crore from the ₹143.8 crore a year earlier as revenue from all but the key U.S. market increased. The ...

Capital inflows into Nigeria surged to $5.6 billion in the first quarter of 2025, representing a 67.12% increase compared to ...

Advanced Enzyme Technologies poised for strong growth in FY26 with improved performance and potential for future expansion.

Lupin posted a strong Q1 with net profit rising 52% YoY to ₹1,219 crore, surpassing estimates. Robust US sales and improved ...

Godfrey Phillips shares have given positive returns despite volatility in market. The stock has ascended over 15 per cent in ...